SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Phathom highlights VOQUEZNA data at ACG 2026

Phathom Pharmaceuticals highlighted new cost-effectiveness data and growing clinical interest in VOQUEZNA (vonoprazan) at ACG 2026.

PHAT